The vaccine, which will be produced locally, is effective and safe, the regulator said. The AstraZeneca-Oxford, Pfizer-BioNTech, Moderna and Johnson Johnson coronavirus vaccines have been in use in South Korea, where 84 percent of the country’s 52 million people are fully vaccinated....
The company later encountered production and clinical delays, while competitors raced ahead. Advertisement Story continues below advertisement The company is now finally poised to produce doses for use worldwide
综合
华盛顿邮报-世界
2022-01-12 00:00:00.0